NCT05919563View on ClinicalTrials.gov

LTFU Study of Subjects Who Received GRNOPC1

Active, not recruitingOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

October 6, 2011

Primary Completion Date

December 12, 2026

Study Completion Date

December 12, 2026

Conditions
Spinal Cord Injuries
Interventions
DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

Observational study; annual MRI for first 5 years only to monitor changes in the injection site

Trial Locations (3)

30309

Shepherd Center, Atlanta

60208

Northwestern Medical Group, Evanston

94304

Stanford University, Palo Alto

Sponsors
All Listed Sponsors
lead

Lineage Cell Therapeutics, Inc.

INDUSTRY

NCT05919563 - LTFU Study of Subjects Who Received GRNOPC1 | Biotech Hunter | Biotech Hunter